{"name":"Perception Neuroscience","slug":"perception-neuroscience","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNRWNZbXpVc01KOXJ0QUtnQ0twYXhuUThqYXJ0czNuWXFHcmRRVnBYZnB1bUVqQ2R3SW16X05HWE1jMGFWNmlMU29WbnRiWmk4Q3MyUE12RktuWUpZVFh4VE90WDZ5WXRlR1ljZEY0TWpZRmNVR0RGSHhLcGQ3NThweVhiMFNFdnpDVTU5RzJVN3lXU05Ca0Y4X0ZYTGs?oc=5","date":"2026-01-12","type":"trial","source":"Frontiers","summary":"Olfactory perception and wellbeing across hormonal contraceptive users and menstrual cycle phases - Frontiers","headline":"Olfactory perception and wellbeing across hormonal contraceptive users and menstrual cycle phases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5aSG4zUjJSYnp5RHR4OHZEa3RuN21yVXI4M210T09hejZ1RmtuTUo2R29sclZ2OUF2N2diUXpXOG5jZk5PUXc2ODFfR1plSmgyOVozblUzLWhOQlhXS3JB?oc=5","date":"2025-12-08","type":"pipeline","source":"Nature","summary":"Patterned wireless transcranial optogenetics generates artificial perception - Nature","headline":"Patterned wireless transcranial optogenetics generates artificial perception","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQcEF4WDhnMlYxRVNranFDMEpGc0VrMWNENEN5Y28wbzRxN0oyb3NVUmlHUUladWw2R1pqdDRjbnA2UDByWmpWdnFfZk9zNlpXWHBuUnRfUHhldy1WcTJ4Y1NMT3lfUVJWRWlVMkZlbXNUZEpJWkVzMHRmZkt2MVZqcHJWZFlIcXRHZldfc3U1QS1FQ01VQ2JEUHQ3dnlVSGtHZkMw?oc=5","date":"2025-11-24","type":"pipeline","source":"New York Post","summary":"Medical advances could be used to develop mind-altering brain weapons, scientists warn: ‘Wake-up call’ - New York Post","headline":"Medical advances could be used to develop mind-altering brain weapons, scientists warn: ‘Wake-up call’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZ05KZUpqb2N2bWZJa2QwSmR3S0Mxbm1RWktwV1BqQTRaTFFWYW5aSzg2MWlBWXhCWnlGTmVnLVBETXc4NFJVUjdEOTVpb1RLQXMzR3R2Vl9Lbnd0UUVSbW13WE5LdFZPbTkzdVA2SjBSTDFIU0owS0dqWnlFOVl0d2FOQ1NoMVhWenU4ZHpUbmxZYkV6VEk0Qjc4YlNWam96YWtVQnlKRVloc28?oc=5","date":"2025-11-14","type":"trial","source":"Pharmafile","summary":"Study finds at-home brain stimulation therapies reduce depression relapse rate - Pharmafile","headline":"Study finds at-home brain stimulation therapies reduce depression relapse rate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1SdDZGVHVjZ2V0OEhvUS1MMGdwZnhkYk1maDFlZlEwV2VYZEU3OWlBQUh1VGVlWnRXT2JXandYbURxempCWnQwSXhpaFBEdWpZcVhoVmhuanowbDlNdTlCX3dOUTRzOHRQckE?oc=5","date":"2025-10-01","type":"regulatory","source":"Psychiatry Online","summary":"Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis - Psychiatry Online","headline":"Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNbGpwR0hTMlI1RWZrRDBqZnVjcWhSell6ZWFkRHlDajJRMTlHRVJmcEZxRVdTc1dsc2g4QUhnNDhWTXh4cHhIVmRpcjh4UjFfRFpTMUVZM1ViR3FucWdmSVJZLW1tZjVrQUZiMi1LUWlmamF5cDZVcktvZU5iM0puaml3SQ?oc=5","date":"2025-08-25","type":"trial","source":"Endpoints News","summary":"AbbVie to buy psychedelic drug from partner Gilgamesh - Endpoints News","headline":"AbbVie to buy psychedelic drug from partner Gilgamesh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxOMHFDM2E1aXZKX010eVJINzVqSDNCVVZIRFVWM1Y0SHpDRDViOWlNSUFKSFQwOWdWZlpNOHZvdTJkNXVCZTZhRFNwd01NU0tFZXdZbk5Bb1g5TGU1T3BVbjRPQ1NaRUlOY3VFSjlVaS1CUkxnTGl0WUlJd3NaMjE3QTRFTXNYQklLS1JWNnpYSmlBZXQ1UUExNk01M1p0M3I4QjZnM1hVQnIyLV9GYkZmNzZpUF9mOHN1V1IxTW5Pa2FsZXNlcU1MZF9tTDFkMTQ2M21seUYtNmU0TzFwVXZHRGk3dmprRDJkZjRsWlRlMXVfLUZOV05ZR0p6bDdocDhDWmdWSllhQ0xkUW5JRFFxWS1MNDJDX2lTZ3FyOFpKcmhHemcyckhabk4zZExYWGZhLW5hT3E4SQ?oc=5","date":"2025-07-23","type":"pipeline","source":"PR Newswire","summary":"Tiny Blue Dot Foundation Awards $9M for Perception Box Neuroscience Exploring Youth Mental Health, Psychedelics, VR Therapy, Body Image, and Emotional Resilience - PR Newswire","headline":"Tiny Blue Dot Foundation Awards $9M for Perception Box Neuroscience Exploring Youth Mental Health, Psychedelics, VR Ther","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPM3VUdXhMb0ZvZzVHbEZHME5fbkdzR1lHMk5rRzZaVEtmaUNnNTBQTHU0RFZsYlZsdnVLUFRqTU4xeW5fblZnWlRlTlRuVXhCYUo5VWZ5WW9IdzgxdnVWRHVvcWNFRjhnX3RxN1BNMkFOcjQ5cXNNWlZrdldBb3VVUWVHSDRJd3g3Y2xWVXh3WEZpQ1dhU0V1SVln?oc=5","date":"2024-06-27","type":"pipeline","source":"Frontiers","summary":"Cognitive Aging and Time Perception: Roles of Bayesian Optimization and Degeneracy - Frontiers","headline":"Cognitive Aging and Time Perception: Roles of Bayesian Optimization and Degeneracy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOTWV6R3RtbFFYbkNuY1RwOG5WNjhWTV9vVUwxSkVNLUdWSXQ1M19mR2pQUEJQbHZJMzlHZ21mZ3lPVUtfOEd2eXRCSmZUZndYaU1JdEloRTh3bjRCek1JYy1qSE5TNWdGalpkQW9Hb2NEYlZNR1RwREZuOHdmeUxQV0ZfY2VzSlV6b2lR?oc=5","date":"2023-08-11","type":"trial","source":"PharmaTimes","summary":"Atai Life delivers results from PCN-101 study - PharmaTimes","headline":"Atai Life delivers results from PCN-101 study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQN2MzOXBRMl8ybUxoZjd1ajlQSDg0NkhfTzNaMjZKVGNqT1hJQVZUU0w2dDkzUURoWDFVTDZ0SkNPLWx5a3d6OVFNOFpmZzRiLWxEdURQUUt6d2RZYS00NWgycVhGS3AxZVFpZ1QtWGRlbnJkZU5MN0Eya2Fxc3dTOV94M29abklvVG9obnUzcDM3VFlEV2drazl3NUlfQ0tQWXVNWV92YkZQbVVKeFZnTXdoT2Zfdw?oc=5","date":"2023-01-06","type":"trial","source":"BioSpace","summary":"atai’s Ketamine-Based Depression Candidate Falls Short in Phase II - BioSpace","headline":"atai’s Ketamine-Based Depression Candidate Falls Short in Phase II","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBIR0lheWJWb04zaGNHQTAxWXRBN21lendfcG9YRkdwTTVuTGRJb1BIX3JmUFhVNUMteWx1SEwxRHJMZTV2S3dkRDZGN1ZISkFwVGRiZlpvUThvZElBVlpB?oc=5","date":"2022-09-06","type":"pipeline","source":"Nature","summary":"Cognitive science theory-driven pharmacology elucidates the neurobiological basis of perception-motor integration - Nature","headline":"Cognitive science theory-driven pharmacology elucidates the neurobiological basis of perception-motor integration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPaTd4X1lJUWdIWDFFNHMzNUY3Z1V4WW9wZGRRWVJxRGhGUXhoc091UXcxdDRTQlRoVlBvckdVQmVKVXotYUxwNzFqTmZBWmQwWW1vVlJnZVF5MTZmcDJHMHVMWHp2TUJWeHk4TF9DN1RNSnNfNFZEWFM0dEN4dEVndA?oc=5","date":"2021-02-22","type":"trial","source":"Clinical Trials Arena","summary":"Perception’s PCN-101 safe and well-tolerated in Phase I clinical study - Clinical Trials Arena","headline":"Perception’s PCN-101 safe and well-tolerated in Phase I clinical study","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}